Varicella Zoster Virus Infection clinical trials
The registry lists 17 studies for Varicella Zoster Virus Infection across 9 countries. 3 are recruiting or about to start. 8 of them are mainly about Varicella Zoster Virus Infection (how this is decided). Per ClinicalTrials.gov, last updated 2026-10-07. Counting its 2 narrower conditions too, such as Herpes Zoster: 448 studies, 80 open.
Get an email when these change. Save the Varicella Zoster Virus Infection studies recruiting or about to start — once a week, free: studies that open, close, add sites or post results.
See an example email
Example · made-up studies
Breast cancer · Recruiting: 2 came in, 3 changed
What changed in your saved searches, Oct 31 – Nov 6:
A study of drug A after surgery for early breast cancer
Came in · now Recruiting
Drug B with hormone therapy in advanced breast cancer
Changed
· Sites: 4 added, including Seoul and Busan
· Enrollment: 300 → 450 participants
Exercise during chemotherapy
Now Active, not recruiting
One email a week for all your saved searches. Stop any time.
Who runs them
Radboud University Medical Center (3) · Susanne Dam Nielsen, MD, DMSc (2) · Shenzhen Shenxin Biotechnology Co., Ltd (2) · Kocaeli University (1) · Asan Medical Center (1) · University of Pisa (1) · Fred Hutchinson Cancer Center (1) · Jiangsu Province Centers for Disease Control and Prevention (1)
What is being tested here
Drugs under test in Varicella Zoster Virus Infection studies, those with the most open studies first. Medicines only given beside them are not counted. How drugs are counted
Coming up
Studies recruiting or running, from their records. “Main data collection” ends at the primary completion date, the sponsor’s own estimate, which often moves.
All 2
- Dec 2026VZV-specific Tissue Resident Memory T-cells After Shingrix Vaccination · University of Washington
- Jan 2027Herpesvirus Immunology in Solid Organ Transplant Recipients - Liver Transplant Study · Susanne Dam Nielsen, MD, DMSc
Who these studies take
Of the 2 Varicella Zoster Virus Infection studies recruiting now, 1 (50%) set no upper age limit and 1 (50%) stop at 75 or younger. 1 (50%) take children under 18. 0 (0%) are for women only and 0 (0%) for men only; 1 (50%) take healthy volunteers.
| Age | Women | Men |
|---|---|---|
| 10 | 1 (50%) | 1 (50%) |
| 18 | 1 (50%) | 1 (50%) |
| 30 | 0 (0%) | 0 (0%) |
| 40 | 1 (50%) | 1 (50%) |
| 50 | 1 (50%) | 1 (50%) |
| 65 | 1 (50%) | 1 (50%) |
| 75 | 1 (50%) | 1 (50%) |
| 85 | 1 (50%) | 1 (50%) |
Across all 17 studies, recruiting or not: 41% stop at 75 or younger and 29% at 65; 29% take children; 0% are for women only and 0% for men only; 53% take healthy volunteers. From each study’s registry entry; the criteria on its page decide.
Studies
Recruiting first, then most recently updated. Showing 17 of 17. search them.
- Long-term Effectiveness of the Live Attenuated Herpes Zoster VaccineRecruitingNCT075853701 country
- A Phase 2 Study to Describe the Safety, Reactogenicity, and Immunogenicity of Herpes Zoster IN001 mRNA Vaccine (IN001) in Healthy ParticipantsNot yet recruitingNCT07205796Phase 2
- Pharmacokinetics of Intravenous Acyclovir in Oncologic Paediatric PatientsRecruitingNCT051985701 country
- Clinical Features and Outcomes of VZV CNS InfectionsCompletedNCT075542611 country
- Herpesvirus Immunology in Solid Organ Transplant Recipients - Liver Transplant StudyActive, not recruitingNCT055325401 country
- Herpes Virus Infections in Kidney Transplant PatientsActive, not recruitingNCT056049111 country
- VZV-specific Tissue Resident Memory T-cells After Shingrix VaccinationActive, not recruitingNCT04403139Phase 41 country
- A Study to Describe the Safety, Reactogenicity, and Immunogenicity of Herpes Zoster IN001 mRNA Vaccine (IN001) in Healthy ParticipantsCompletedNCT06375512Phase 12 countries
- Clinical Trial to Evaluate EuHZV in Healthy Adults Aged 50 to 69 YearsActive, not recruitingNCT06409494Phase 11 country
- An Open-label, Bridging Study of BARYCELA Inj. in Healthy Vietnamese Children Aged Between 12 Months to 12 YearsStatus unknownNCT05664152Not applicable
- Pharmacokinetics of Valacyclovir Oral Solution in ChildrenTerminatedNCT04081480Not applicable1 country
- Bioequivalence Study in Healthy Volunteers of a New Paediatric Formulation of ValacyclovirCompletedNCT01689285Phase 11 country
- Palatability Testing of a New Paediatric Formulation of ValacyclovirCompletedNCT01682109Phase 41 country
- VZV Vaccine for Hematopoietic Stem Cell TransplantationCompletedNCT02329457Phase 2/31 country
- Reversible Cerebral Vasoconstriction Syndrome and Varicella Zoster VirusStatus unknownNCT035097011 country
- A Retrospective Chart Review Study of Gene-Eden-VIR/NovirinCompletedNCT027157521 country
- Long-Term Oral Acyclovir Usage to Prevent Herpes Zoster Virus Infection After Bone Marrow TransplantCompletedNCT00209352Phase 31 country